• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球、区域和国家恶性皮肤黑色素瘤发病率趋势分析 1990 年至 2019 年,并预测至 2034 年。

Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034.

机构信息

Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Cancer Control. 2024 Jan-Dec;31:10732748241227340. doi: 10.1177/10732748241227340.

DOI:10.1177/10732748241227340
PMID:38227397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10793190/
Abstract

BACKGROUND

The goal of this study was to evaluate the global burden of malignant skin melanoma (MSM) from 1990 to 2019 using MSM-related data from the Global Burden of Disease study.

METHODS

The incidences' relationships with the social-demographic index (SDI) and human developmental index (HDI) were investigated. To determine significant changes in incidence trends, the joinpoint regression model was used. To demonstrate trends in MSM mortality rates, an Age-Period-Cohort framework was conducted. For the projection of new cases and the age-standardized incidence rate (ASR) of MSM incidence to 2034, the Nordpred method was used.

RESULTS

In 2019, the ASR incidence per 100, 000 people for MSM was 3.6 (95% UI, 2.6-4.2). MSM prevalence increased in most countries between 1990 and 2019 (average annual percentage change >0). HDI and annual percentage change (APC) (ρ = .63, < .001), as well as SDI and ASR, had a positive correlation. The total MSM mortality rate declined globally, with an APC of -.61%. Likewise, the mortality rate for the age group of people with ages <77.5 years declined. Predictive analysis demonstrated a declining trend in ASR incidence and a growing number of MSM.

CONCLUSION

There are significant differences in ASR incidence among regions and countries. Despite decreases in ASR incidence and fatality, MSM remains one of the leading sources of cancer mortality and morbidity globally. MSM necessitates more primary prevention measures and screening in high-risk areas.

摘要

背景

本研究旨在利用全球疾病负担研究中与恶性皮肤黑色素瘤(MSM)相关的数据,评估 1990 年至 2019 年期间 MSM 的全球负担。

方法

研究分析了发病率与社会人口指数(SDI)和人类发展指数(HDI)的关系。为了确定发病率趋势的显著变化,采用了 joinpoint 回归模型。为了展示 MSM 死亡率趋势,采用了年龄-时期-队列框架。为了预测新发病例和 MSM 发病率的年龄标准化发病率(ASR)到 2034 年,采用了 Nordpred 方法。

结果

2019 年,MSM 的每 100,000 人发病率为 3.6(95%置信区间,2.6-4.2)。1990 年至 2019 年间,大多数国家的 MSM 患病率都有所增加(平均年百分比变化>0)。HDI 和年百分比变化(APC)(ρ=0.63,<0.001)以及 SDI 和 ASR 呈正相关。全球 MSM 死亡率总体呈下降趋势,APC 为-0.61%。同样,年龄<77.5 岁人群的死亡率也有所下降。预测分析显示 ASR 发病率呈下降趋势,MSM 人数不断增加。

结论

各地区和国家之间的 ASR 发病率存在显著差异。尽管 ASR 发病率和死亡率有所下降,但 MSM 仍然是全球癌症死亡和发病的主要原因之一。MSM 需要在高风险地区采取更多的初级预防措施和筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/f692981acd75/10.1177_10732748241227340-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/464429bd716b/10.1177_10732748241227340-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/0191967510fe/10.1177_10732748241227340-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/ff0f9bc18b2c/10.1177_10732748241227340-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/f692981acd75/10.1177_10732748241227340-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/464429bd716b/10.1177_10732748241227340-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/0191967510fe/10.1177_10732748241227340-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/ff0f9bc18b2c/10.1177_10732748241227340-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa8/10793190/f692981acd75/10.1177_10732748241227340-fig4.jpg

相似文献

1
Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034.全球、区域和国家恶性皮肤黑色素瘤发病率趋势分析 1990 年至 2019 年,并预测至 2034 年。
Cancer Control. 2024 Jan-Dec;31:10732748241227340. doi: 10.1177/10732748241227340.
2
Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019.全球、区域和国家的皮肤癌发病率、死亡率和伤残调整生命年以及 1990 年至 2019 年的趋势分析:2019 年全球疾病负担研究分析。
Cancer Med. 2021 Jul;10(14):4905-4922. doi: 10.1002/cam4.4046. Epub 2021 Jun 9.
3
Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast.全球炎症性肠病负担 1990-2019 年:疾病负担的系统评估和二十年预测。
World J Gastroenterol. 2023 Nov 14;29(42):5751-5767. doi: 10.3748/wjg.v29.i42.5751.
4
Changing trends in the disease burden of uterine cancer globally from 1990 to 2019 and its predicted level in 25 years.1990年至2019年全球子宫癌疾病负担的变化趋势及其未来25年的预测水平。
Front Oncol. 2024 Apr 22;14:1361419. doi: 10.3389/fonc.2024.1361419. eCollection 2024.
5
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.全球、地区和国家子宫纤维瘤发病率、患病率和残疾生存年数的时间趋势,1990-2019 年:对 2019 年全球疾病负担研究的年龄-时期-队列分析。
BMC Public Health. 2023 May 19;23(1):916. doi: 10.1186/s12889-023-15765-x.
6
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
7
Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019.2019 年全球疾病负担研究:1990 年至 2019 年全球、区域和国家多发性硬化症负担。
Front Public Health. 2023 Feb 17;11:1073278. doi: 10.3389/fpubh.2023.1073278. eCollection 2023.
8
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years.全球非黑色素瘤皮肤癌疾病负担的变化趋势:1990 年至 2019 年及其 25 年后的预测水平。
BMC Cancer. 2022 Jul 30;22(1):836. doi: 10.1186/s12885-022-09940-3.
9
Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的气管、支气管和肺癌的时间趋势,与全球数据比较。
Thorac Cancer. 2023 Jun;14(18):1668-1706. doi: 10.1111/1759-7714.14912. Epub 2023 May 1.
10
Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019.全球和国家矽肺死亡率和伤残调整生命年的负担和趋势,1990 年至 2019 年:2019 年全球疾病负担研究结果。
BMC Pulm Med. 2022 Jun 21;22(1):240. doi: 10.1186/s12890-022-02040-9.

引用本文的文献

1
Patterns and trends in melanoma mortality in Spain (1999-2022).西班牙黑色素瘤死亡率的模式与趋势(1999 - 2022年)
Clin Transl Oncol. 2025 May;27(5):2339-2346. doi: 10.1007/s12094-024-03747-3. Epub 2024 Oct 5.
2
Skin lesion segmentation using deep learning algorithm with ant colony optimization.基于蚁群算法的深度学习算法在皮肤损伤分割中的应用。
BMC Med Inform Decis Mak. 2024 Sep 27;24(1):265. doi: 10.1186/s12911-024-02686-x.
3
A Mendelian randomization study of genetic liability to cutaneous melanoma and sunburns.一项关于皮肤黑色素瘤和晒伤遗传易感性的孟德尔随机化研究。

本文引用的文献

1
Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.单细胞测序分析与鞘脂代谢相关,指导皮肤黑色素瘤的免疫治疗和预后。
Front Immunol. 2023 Nov 23;14:1304466. doi: 10.3389/fimmu.2023.1304466. eCollection 2023.
2
Global, regional, and national thyroid cancer age-period-cohort modeling and Bayesian predictive modeling studies: A systematic analysis of the global burden of disease study 2019.全球、区域和国家甲状腺癌年龄-时期-队列建模及贝叶斯预测建模研究:2019年全球疾病负担研究的系统分析
Heliyon. 2023 Nov 16;9(11):e22490. doi: 10.1016/j.heliyon.2023.e22490. eCollection 2023 Nov.
3
Front Oncol. 2024 Aug 30;14:1393833. doi: 10.3389/fonc.2024.1393833. eCollection 2024.
4
Spain's Rising Melanoma Threat: A Comprehensive 30-Year Analysis (1990-2019).西班牙不断上升的黑色素瘤威胁:一项为期30年的综合分析(1990 - 2019年)
Cancers (Basel). 2024 Mar 15;16(6):1167. doi: 10.3390/cancers16061167.
Acral Lentiginous Melanoma: A Clinicoprognostic Study of 149 Cases at a Single Institution.
肢端雀斑样痣黑色素瘤:单机构149例临床预后研究
Am Surg. 2024 Apr;90(4):600-606. doi: 10.1177/00031348231204915. Epub 2023 Sep 26.
4
Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019.1990年至2019年全球、区域和国家唐氏综合征的负担及趋势
Front Genet. 2022 Jul 15;13:908482. doi: 10.3389/fgene.2022.908482. eCollection 2022.
5
Targeting EGFR in melanoma - The sea of possibilities to overcome drug resistance.靶向黑色素瘤中的 EGFR-克服耐药性的可能性之海。
Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188754. doi: 10.1016/j.bbcan.2022.188754. Epub 2022 Jun 27.
6
A Decade of Success in Melanoma Immunotherapy and Targeted Therapy: What Every Radiologist Should Know.黑色素瘤免疫治疗和靶向治疗十年来的成功:放射科医生应该知道的一切。
J Comput Assist Tomogr. 2022;46(4):621-632. doi: 10.1097/RCT.0000000000001315. Epub 2022 Jun 4.
7
The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990-2017.皮肤癌的全球负担:来自1990 - 2017年全球疾病负担研究的纵向分析。
JAAD Int. 2021 Jan 4;2:98-108. doi: 10.1016/j.jdin.2020.10.013. eCollection 2021 Mar.
8
Burden of skin disease and associated socioeconomic status in Asia: A cross-sectional analysis from the Global Burden of Disease Study 1990-2017.亚洲皮肤病负担及其相关社会经济状况:一项基于1990 - 2017年全球疾病负担研究的横断面分析。
JAAD Int. 2020 Dec 10;2:40-50. doi: 10.1016/j.jdin.2020.10.006. eCollection 2021 Mar.
9
Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019.全球、区域和国家的皮肤癌发病率、死亡率和伤残调整生命年以及 1990 年至 2019 年的趋势分析:2019 年全球疾病负担研究分析。
Cancer Med. 2021 Jul;10(14):4905-4922. doi: 10.1002/cam4.4046. Epub 2021 Jun 9.
10
United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.美国 1990 年至 2019 年黑色素瘤和非黑色素瘤皮肤癌负担。
J Am Acad Dermatol. 2021 Aug;85(2):388-395. doi: 10.1016/j.jaad.2021.03.109. Epub 2021 Apr 20.